Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy ...

AMGN Factor-Based Stock Analysis June 11, 2025 — 12:06 pm EDT Written by John Reese for Validea -> ...

In the latest close session, Amgen (AMGN) was up +1.88% at $297.29. The stock outpaced the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.24%, and the technology ...

AMGN boasts a Value Style Score of B and VGM Score of A, and holds a Zacks Rank #3 (Hold) rating. Shares of Amgen are trading at a forward earnings multiple of 13.9X, as well as a PEG Ratio of 2.6 ...

Current Position of Amgen. With a trading volume of 951,644, the price of AMGN is up by 0.32%, reaching $291.26. Current RSI values indicate that the stock is may be approaching overbought.

Amgen (NasdaqGS:AMGN) recently announced interim results from its Phase 3 DeLLphi-304 trial for IMDELLTRA, showing significant improvement in survival outcomes for SCLC patients. This announcement ...

Amgen Inc. (NASDAQ:AMGN)’s thrombocytopenia drug Nplate (romiplostim) showed significant benefits in a Phase III trial for gastrointestinal (GI) cancer patients, as presented at the 2025 ASCO ...

Let's consider two examples in the healthcare sector: Amgen (AMGN 1.03%) and Novartis (NVS-0.77%). These drugmakers have a lot to offer long-term, income-oriented investors.

Amgen is a dividend stock with a ton of upside. David Jagielski (Amgen): One of the best healthcare stocks to buy in June is Amgen.Although it's been doing poorly over the past 12 months, dropping ...

View the latest Amgen Inc. (AMGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.